{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:36:11Z","timestamp":1790285771801,"version":"4.1.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T00:00:00Z","timestamp":1542844800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2018.02849","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T05:18:44Z","timestamp":1542863924000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Inhibitory Effect of Ursodeoxycholic Acid on Clostridium difficile Germination Is Insufficient to Prevent Colitis: A Study in Hamsters and Humans"],"prefix":"10.3389","volume":"9","author":[{"given":"Lola-Jade","family":"Palmieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Rainteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Sokol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Beaugerie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Dior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Coffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydie","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Eguether","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Bado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Hoys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Janoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Duboc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102848","article-title":"Healthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, Texas.","volume":"9","author":"Aitken","year":"2014","journal-title":"PLoS One"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv004","article-title":"Weight gain after fecal microbiota transplantation.","volume":"2","author":"Alang","year":"2015","journal-title":"Open Forum Infect. Dis."},{"key":"B3","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0016-5085(82)80003-6","article-title":"Comparative formation of lithocholic acid from chenodeoxycholic and ursodeoxycholic acids in the colon.","volume":"83","author":"Bazzoli","year":"1982","journal-title":"Gastroenterology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1128\/JB.00908-15","article-title":"Reexamining the germination phenotypes of several Clostridium difficile strains suggests another role for the CspC germinant receptor.","volume":"198","author":"Bhattacharjee","year":"2016","journal-title":"J. Bacteriol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ajg.2012.60","article-title":"Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.","volume":"107","author":"Brandt","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nature13828","article-title":"Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile.","volume":"517","author":"Buffie","year":"2015","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/hep.1840140609","article-title":"Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration.","volume":"14","author":"Crosignani","year":"1991","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1469-0691.12418","article-title":"European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection.","volume":"20","author":"Debast","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1038\/ajg.2011.156","article-title":"High-dose Ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.","volume":"106","author":"Eaton","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases.","volume":"51","year":"2009","journal-title":"J. Hepatol."},{"key":"B11","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0016-5085(79)80079-7","article-title":"Transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal bacteria.","volume":"77","author":"Fedorowski","year":"1979","journal-title":"Gastroenterology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003356","article-title":"Bile acid recognition by the Clostridium difficile germinant receptor, CspC, is important for establishing infection.","volume":"9","author":"Francis","year":"","journal-title":"PLoS Pathog."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073653","article-title":"Muricholic acids inhibit Clostridium difficile spore germination and growth.","volume":"8","author":"Francis","year":"","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jchromb.2012.05.015","article-title":"Bile acid profiling in human biological samples: comparison of extraction procedures and application to normal and cholestatic patients.","volume":"899","author":"Humbert","year":"2012","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/1574-6968.12367","article-title":"Small animal models for the study of Clostridium difficile disease pathogenesis.","volume":"352","author":"Hutton","year":"2014","journal-title":"FEMS Microbiol. Lett."},{"key":"B16","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/gutjnl-2012-303867","article-title":"Letter to the editor regarding the report of Duboc et al.: connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel disease.","volume":"62","author":"Jones","year":"2013","journal-title":"Gut"},{"key":"B17","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States.","volume":"372","author":"Lessa","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s40121-016-0135-9","article-title":"Epidemiology and recurrence rates of Clostridium difficile infections in germany: a secondary data analysis.","volume":"5","author":"L\u00fcbbert","year":"2016","journal-title":"Infect. Dis. Ther."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081112","article-title":"Immunization using GroEL decreases Clostridium difficile intestinal colonization.","volume":"8","author":"P\u00e9chin\u00e9","year":"2013","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1126\/science.1241214","article-title":"Gut microbiota from twins discordant for obesity modulate metabolism in mice.","volume":"341","author":"Ridaura","year":"2013","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile salt biotransformations by human intestinal bacteria.","volume":"47","author":"Ridlon","year":"2006","journal-title":"J. Lipid Res."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170640","article-title":"Development of a novel vaccine containing binary toxin for the prevention of Clostridium difficile disease with enhanced efficacy against NAP1 strains.","volume":"12","author":"Secore","year":"2017","journal-title":"PLoS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/cid\/civ958","article-title":"Clinical and healthcare burden of multiple recurrences of Clostridium difficile infection.","volume":"62","author":"Sheitoyan-Pesant","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.3748\/wjg.14.3497","article-title":"Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis.","volume":"14","author":"Sokol","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.dld.2017.01.162","article-title":"Clostridium difficile infection in acute flares of inflammatory bowel disease: a prospective study.","volume":"49","author":"Sokol","year":"2017","journal-title":"Dig. Liver Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1128\/JB.01765-07","article-title":"Bile salts and glycine as cogerminants for Clostridium difficile spores.","volume":"190","author":"Sorg","year":"2008","journal-title":"J. Bacteriol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1128\/JB.00610-10","article-title":"Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid.","volume":"192","author":"Sorg","year":"2010","journal-title":"J. Bacteriol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/ajg.2013.4","article-title":"Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.","volume":"108","author":"Surawicz","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00045-15","article-title":"Antibiotic-induced alterations of the Gut microbiota alter secondary bile acid production, and allow for Clostridium difficile spore germination, and outgrowth in the large intestine.","volume":"1","author":"Theriot","year":"2016","journal-title":"mSphere"},{"key":"B31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.dld.2011.10.025","article-title":"Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.","volume":"44","author":"Trottier","year":"2012","journal-title":"Dig. Liver Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile.","volume":"368","author":"van Nood","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy568","article-title":"Repurposing an old drug for a new epidemic: ursodeoxycholic acid to prevent recurrent clostridioides difficile infection.","author":"Webb","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"G310","DOI":"10.1152\/ajpgi.00282.2013","article-title":"Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection.","volume":"306","author":"Weingarden","year":"2014","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/MCG.0000000000000427","article-title":"Ursodeoxycholic acid inhibits Clostridium difficile spore germination and vegetative growth, and prevents the recurrence of ileal pouchitis associated with the infection.","volume":"50","author":"Weingarden","year":"2015","journal-title":"J. Clin. Gastroenterol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147210","article-title":"Changes in colonic bile acid composition following fecal microbiota transplantation are sufficient to control Clostridium difficile germination and growth.","volume":"11","author":"Weingarden","year":"2016","journal-title":"PLoS One"},{"key":"B37","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1128\/JCM.15.3.443-446.1982","article-title":"Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile.","volume":"15","author":"Wilson","year":"1982","journal-title":"J. Clin. Microbiol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.02849\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T18:55:08Z","timestamp":1605466508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.02849\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,22]]},"references-count":37,"alternative-id":["10.3389\/fmicb.2018.02849"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2018.02849","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,22]]},"article-number":"2849"}}